Levima Advanced Materials Corporation (003022.SZ) Bundle
Curious whether Levima Advanced Materials (003022.SZ) is a turnaround story or a balance-sheet risk? The company posted an operating income of 1.539 billion yuan in Q1 2025 (up 3.48% YoY and 18.27% MoM) while trailing twelve-month revenue through Sept 30, 2025 totaled 5.87 billion yuan (down 13.79% YoY) after a 2024 full-year revenue of 6.27 billion yuan; despite that top-line pressure Levima still reported a 2024 net profit of 234 million yuan (down 47.45% YoY) and delivered a Q1 2025 net profit of 71 million yuan with a Q1 gross margin of 31%, but investors should weigh those operating gains against a leveraged footprint-cash and equivalents of 2.69 billion yuan leave a net cash position of -10.24 billion yuan and an Altman Z-Score of 1.27-and high market expectations (P/E 87.12, EV/EBITDA 39.19) alongside heavy capex (3.92 billion yuan H1 2025) and growth bets like a 200,000 tpa EVA line and PO/PP/VC projects coming online in 2025; read on for a deep dive into revenue drivers, margins, liquidity, valuation, and the risks versus the strategic expansion underpinning Levima's outlook.
Levima Advanced Materials Corporation (003022.SZ) Revenue Analysis
Levima Advanced Materials Corporation (003022.SZ) shows mixed short-term momentum against a weakening annual trend. Key reported figures and drivers for revenue and profitability in recent periods are summarized below.
- Q1 2025 operating income: 1.539 billion yuan - up 3.48% year-on-year (YoY) and up 18.27% month-on-month (MoM).
- TTM revenue ending 30 Sep 2025: 5.87 billion yuan - down 13.79% YoY.
- Full-year 2024 revenue: 6.27 billion yuan - down 7.52% vs. 2023.
- 2024 net profit: 234 million yuan - down 47.45% YoY.
- Non-recurring gains and losses declined by ~220 million yuan, materially weighing on net income.
- Management cites reduced support funds for enterprise development and lower non-recurring items as primary causes of revenue and profit decline.
| Metric | Period | Value (CNY) | Change |
|---|---|---|---|
| Operating income | Q1 2025 | 1.539 billion | +3.48% YoY; +18.27% MoM |
| Total revenue (TTM) | Ending 30 Sep 2025 | 5.87 billion | -13.79% YoY |
| Annual revenue | 2024 | 6.27 billion | -7.52% vs 2023 |
| Net profit | 2024 | 234 million | -47.45% YoY |
| Impact from non-recurring items | 2024 vs prior | ~220 million reduction | Significant negative impact on net income |
Investor considerations:
- Q1 2025 recovery suggests operational resilience or seasonal improvement, but TTM and 2024 trends point to sustained top-line pressure.
- Large swing in non-recurring items (~220 million yuan) highlights earnings volatility and the need to adjust normalized profit expectations.
- Reduced external support funds for enterprise development may imply lower one-off revenue streams or subsidies; monitor policy/funding changes.
- Watch subsequent quarterly reports for confirmation of revenue stabilization or continuation of the decline seen in TTM figures.
Related background and corporate context: Levima Advanced Materials Corporation: History, Ownership, Mission, How It Works & Makes Money
Levima Advanced Materials Corporation (003022.SZ) - Profitability Metrics
Levima reported weakening full-year profitability in 2024 but showed a notable operational rebound in early 2025.- Net profit margin: 4.9% (2023) → 3.7% (2024).
- Diluted EPS: 0.33 yuan (2023) → 0.18 yuan (2024).
- Q1 2025 net profit: 71 million yuan, up 38.83% year‑on‑year and 27.27% month‑on‑month.
- Q1 2025 gross profit margin: 31%.
- Trailing‑12‑month operating cash flow (ending Sep 30, 2025): 594 million yuan.
| Metric | 2023 | 2024 | Q1 2025 / TTM |
|---|---|---|---|
| Net profit margin | 4.9% | 3.7% | - (Q1 2025 shows margin recovery via gross margin) |
| Diluted EPS (yuan) | 0.33 | 0.18 | - |
| Net profit (quarter) | - | - | 71 million yuan (Q1 2025) |
| Gross profit margin | - | - | 31% (Q1 2025) |
| Operating cash flow (TTM) | - | - | 594 million yuan (ending Sep 30, 2025) |
- Primary drivers of Q1 2025 improvement:
- Optimized operations and stable equipment performance.
- Increased sales of EVA products, boosting volume and mix.
- Stronger cash generation supporting operational flexibility.
Levima Advanced Materials Corporation (003022.SZ) - Debt vs. Equity Structure
Key capital-structure metrics through late 2025 show Levima carrying significant leverage alongside sizable ongoing investment and constrained operating cash generation.
| Metric | Value (CNY) | Notes / Date |
|---|---|---|
| Total debt | 12.93 billion | As of 2025-11-28 |
| Cash & cash equivalents | 2.69 billion | As of 2025-11-28 |
| Net cash / (debt) | -10.24 billion | Total debt minus cash |
| Debt-to-equity ratio | 1.61 | As of 2025-11-28 |
| Interest coverage ratio | 2.73 | Trailing measure of EBIT / interest expense |
| Total assets (projected) | 21.714 billion | Projection for 2025 |
| Debt ratio (Total liabilities / Total assets) | 62.4% | 2025 projection |
| Capital expenditures (H1 2025) | 3.92 billion | First half of 2025 |
| Operating cash flow (TTM to 2025-09-30) | 439.49 million | Trailing twelve months |
- Leverage profile: Debt-to-equity of 1.61 and net debt of ~10.24 billion indicate a capital structure tilted toward borrowed funds.
- Asset backing: Projected total assets of 21.714 billion imply a debt ratio of 62.4%, meaning liabilities represent the majority of the balance sheet.
- Liquidity buffer: Cash of 2.69 billion covers only ~20.8% of total debt, leaving limited short-term liquidity headroom.
Operational cash generation versus investment and interest obligations:
- Operating cash flow (TTM to 2025-09-30): 439.49 million - relatively small compared with interest-bearing debt and ongoing capex.
- Interest coverage: 2.73 - the company can meet interest payments but has limited cushion for shocks or rising rates.
- Capex intensity: 3.92 billion in H1 2025 signals heavy investment that may depress free cash flow in the near term.
Immediate financial considerations for investors:
- Refinancing and maturity risk given large outstanding debt (12.93 billion) and negative net cash.
- Potential pressure on credit metrics if operating cash flow does not ramp to support capex and interest.
- Asset growth (21.714 billion) provides collateral but also reflects substantial capital deployed into ongoing projects.
For context on corporate direction and how capital allocation ties to strategy, see: Mission Statement, Vision, & Core Values (2026) of Levima Advanced Materials Corporation.
Levima Advanced Materials Corporation (003022.SZ) - Liquidity and Solvency
Levima's near-term liquidity profile and capital structure indicate material stress: short-term coverage metrics are weak, leverage is high, and cash flows appear strained relative to debt obligations.- Current ratio: 0.70 - below 1.0, signaling potential difficulty meeting short-term liabilities with current assets.
- Quick ratio: 0.46 - limited immediate liquidity when inventories are excluded.
- Altman Z-Score: 1.27 - in the zone associated with elevated bankruptcy risk.
- Operating cash flow (TTM to 2025-09-30): ¥439.49 million - positive but modest relative to reported liabilities and net debt.
- Net cash position: ¥-10.24 billion - net debtor position indicating substantial net borrowings.
- Interest coverage ratio: 2.73 - earnings available to cover interest are limited, offering modest cushion.
- Total assets (projected 2025): ¥21.714 billion; debt ratio: 62.4% - indicating a leveraged balance sheet.
| Metric | Value | Interpretation |
|---|---|---|
| Current Ratio | 0.70 | Insufficient short-term asset coverage |
| Quick Ratio | 0.46 | Thin immediate liquidity |
| Altman Z-Score | 1.27 | Elevated bankruptcy risk |
| Operating Cash Flow (TTM to 2025-09-30) | ¥439.49 million | Modest cash generation vs. liabilities |
| Net Cash Position | ¥-10.24 billion | Net debt burden |
| Interest Coverage Ratio | 2.73 | Limited ability to absorb higher interest |
| Total Assets (Projected 2025) | ¥21.714 billion | Balance sheet scale |
| Debt Ratio | 62.4% | Total liabilities represent majority of capital structure |
| Estimated Total Liabilities (2025) | ¥13.547 billion | Total Assets × Debt Ratio (21.714 × 0.624) |
| Estimated Equity (2025) | ¥8.167 billion | Total Assets - Estimated Liabilities |
- Operational/cash-flow concerns: Operating cash flow of ¥439.49M vs. net debt of ¥10.24B implies reliance on refinancing, asset sales, or capital raises to materially improve liquidity.
- Leverage profile: A 62.4% debt ratio and negative net cash position make the firm sensitive to interest-rate moves and margin compression despite an interest coverage ratio above 1.0.
- Bankruptcy-risk signal: Altman Z-Score of 1.27 places Levima in a high-risk bracket, warranting close monitoring of covenant headroom and near-term maturities.
Levima Advanced Materials Corporation (003022.SZ) - Valuation Analysis
Key valuation metrics for Levima Advanced Materials Corporation (003022.SZ) highlight a richly priced equity with mixed signals on profitability versus cash generation. Below are the core figures investors should weigh:
- Market capitalization: 25.84 billion yuan
- Enterprise value (EV): 36.72 billion yuan
- Trailing P/E: 87.12
- Price-to-Sales (P/S): 4.40
- Price-to-Book (P/B): 3.23
- Earnings yield: 1.12%
- Free cash flow yield: -13.46%
- EV/EBITDA: 39.19
- EV/EBIT: 100.92
Investors should consider relative and absolute valuation lenses - valuation multiples versus peers and historical averages, and cash-flow based measures given the negative free cash flow yield.
| Metric | Value | Interpretation |
|---|---|---|
| Market Cap | 25.84 billion CNY | Equity market size |
| Enterprise Value | 36.72 billion CNY | Debt‑adjusted valuation |
| Trailing P/E | 87.12 | High earnings multiple - strong growth expectations or low current earnings |
| P/S | 4.40 | Premium to revenue |
| P/B | 3.23 | Market prices several times book value |
| Earnings Yield | 1.12% | Low implied return from earnings |
| Free Cash Flow Yield | -13.46% | Negative cash generation per market cap |
| EV/EBITDA | 39.19 | Very high multiple vs. operating cash proxy |
| EV/EBIT | 100.92 | Extremely high relative to operating profit |
Key implications to consider:
- High P/E and EV multiples imply the market is pricing substantial future growth or premium margins; downside risk exists if growth misses expectations.
- Negative free cash flow yield (-13.46%) signals cash conversion issues; vigilance on working capital, capital expenditures, and one‑off items is necessary.
- Low earnings yield (1.12%) makes the stock sensitive to multiple compression; a small decline in valuation multiples can materially impact returns.
- EV/EBITDA (39.19) and EV/EBIT (100.92) suggest limited margin for error versus peers - profitability improvements or de‑leveraging would be needed to justify current EV.
For additional context on corporate strategy and long-term objectives see: Mission Statement, Vision, & Core Values (2026) of Levima Advanced Materials Corporation.
Levima Advanced Materials Corporation (003022.SZ) - Risk Factors
- Altman Z-Score: 1.27 - indicates elevated bankruptcy risk and financial distress vulnerability.
- Debt-to-Equity Ratio: 1.61 - a leveraged capital structure that increases solvency and refinancing risk.
- Liquidity Ratios: Current Ratio 0.70; Quick Ratio 0.46 - potential short-term liquidity pressure and limited ability to meet immediate obligations.
- Free Cash Flow Yield: -13.46% - negative FCF yield signals that capital returns or reinvestment are not being supported by free cash generation.
- Operating Cash Flow (TTM to 2025-09-30): ¥439.49 million - positive operating cash flow but may be insufficient versus financing and capex needs, implying liquidity strain.
- Valuation Multiples: EV/EBITDA 39.19; EV/EBIT 100.92 - the enterprise value is high relative to earnings, increasing valuation and downside risk if earnings disappoint.
| Metric | Value | Interpretation |
|---|---|---|
| Altman Z-Score | 1.27 | High bankruptcy risk zone |
| Debt-to-Equity Ratio | 1.61 | Leveraged balance sheet |
| Current Ratio | 0.70 | Below 1 - weak short-term coverage |
| Quick Ratio | 0.46 | Low immediate liquidity |
| Free Cash Flow Yield | -13.46% | Negative cash return to investors |
| Operating Cash Flow (TTM to 2025-09-30) | ¥439.49M | Positive OCF but potential strain vs. obligations |
| EV/EBITDA | 39.19 | High multiple - valuation risk |
| EV/EBIT | 100.92 | Extremely high relative to operating earnings |
- Operational and market sensitivity: high leverage and thin liquidity amplify exposure to revenue volatility, input-cost swings, and cyclical demand in advanced materials markets.
- Refinancing and interest-rate risk: elevated debt-to-equity and negative FCF yield raise the probability of refinancing stress if credit conditions tighten.
- Valuation downside: steep EV multiples mean negative earnings surprises would likely lead to disproportionate share price declines.
- Working capital pressure: current and quick ratios below 1 suggest reliance on external financing or asset sales to meet short-term needs.
Levima Advanced Materials Corporation (003022.SZ) Growth Opportunities
Levima is executing a multi-pronged capacity expansion and diversification strategy across polymer, electronic and battery materials, targeting commercialization ramps in 2024-2025 and strategic partnerships to capture higher-value end-markets. Key initiatives and timelines are summarized below.- EVA expansion: new 200,000 tons/year EVA facility under construction, expected online in 2025 to serve packaging, photovoltaic encapsulants and adhesive markets.
- UHMWPE & POE development: launched a 20,000 tons/year UHMWPE facility in March 2024; ongoing POE scale-up projects to increase exposure to specialty elastomers.
- Biodegradable materials: PPC (polypropylene carbonate) project slated for 2025 start-up to address biodegradable polymer demand.
- Electronic materials: targeted investments in semiconductor packaging materials to deepen presence in high-margin electronic materials segments.
- New-materials megaprojects: pipeline includes 0.3 million tons/year PO, 0.05 million tons/year PPC and 4,000 tons/year lithium battery additive VC, all expected to be operational in 2025.
- Battery materials JV: joint venture with solid-state battery leader Weilan New Energy Fund to develop functional materials for next-generation batteries.
| Project | Capacity (tons/year) | Commercial Target | Expected Online | Status (as of 2024-2025) |
|---|---|---|---|---|
| EVA facility | 200,000 | Photovoltaic encapsulant, adhesives | 2025 | Under construction |
| UHMWPE plant | 20,000 | High-performance polyethylene (armor, medical, industrial) | Mar 2024 | Launched |
| PO (polyolefin) project | 300,000 | General and specialty polyolefins | 2025 | Planned/expected |
| PPC (biodegradable PPC) | 50,000 | Biodegradable plastics | 2025 | Planned/expected |
| VC (lithium battery additive) | 4,000 | Battery electrolyte additive | 2025 | Planned/expected |
| Semiconductor packaging materials | N/A | Electronic materials (high-margin) | Ongoing | Strategic investments made |
| JV with Weilan New Energy Fund | N/A | Solid-state battery functional materials | Ongoing | Established |
- Strategic impact: scaling EVA (200k tpa) and PO (300k tpa) materially increases Levima's commodity & specialty polymer output, while UHMWPE, PPC and VC lines aim to improve product mix and margins.
- Timing concentration: multiple 2025 start-ups create a near-term capital-intensity and execution risk profile but offer step-change revenue potential upon commissioning.
- Partnership leverage: the JV with Weilan New Energy Fund positions Levima in advanced battery materials for solid-state applications, enhancing long-term growth optionality.

Levima Advanced Materials Corporation (003022.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.